✦ LIBER ✦

Clinical outcomes of selective stenting as treatment for renovascular hypertension caused by aortoarteritis

✍ Scribed by XIONG-JING JIANG; QIAN YANG; YUE-JIN YANG; HAI-YING WU; HUI-MING ZHANG; BO XU; RU-TAI HUI; RUN-LIN GAO

Book ID: 116548580
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 84 KB
Volume: 137
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2009.09.161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Application of Self-Expandable

Clinical Application of Self-Expandable Metallic Stent for Treatment of Colorectal Obstruction Caused by Extrinsic Invasive Tumors

✍ Sung Jae Shin; Tae Il Kim; Byung Chang Kim; Yong Chan Lee; Si Young Song; Won Ho 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 159 KB

Clinical Outcomes with Ertapenem as a Fi

Clinical Outcomes with Ertapenem as a First-Line Treatment Option of Infections Caused by Extended-Spectrum -Lactamase Producing Gram-Negative Bacteria

✍ Fong, J. J.; Rose, L.; Radigan, E. A. 📂 Article 📅 2012 🏛 Harvey Whitney Books Company 🌐 English ⚖ 177 KB

Final kissing balloon inflation by class

Final kissing balloon inflation by classic crush stenting did not improve the clinical outcomes for the treatment of unprotected left main bifurcation lesions: The importance of double-kissing crush technique

✍ Shaoliang Chen; Junjie Zhang; Fei Ye; Yundai Chen; Weiyi Fang; Meng Wei; Ben He; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

IS protein-losing enteropathy a signific

IS protein-losing enteropathy a significant complication of portal hypertension?: Stanley AJ, Gilmour HM, Ghosh S, et al. Transjugular Intrahepatic Portosystemic Shunt as a Treatment for Protein-Losing Enteropathy Caused by Portal Hypertension Gastroenterology 1996;111:1679–82

✍ Harold O. Conn 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB

A bioresorbable everolimus-eluting scaff

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

✍ Serruys, Patrick W; Chevalier, Bernard; Dudek, Dariusz; Cequier, Angel; Carrié, 📂 Article 📅 2015 🏛 The Lancet 🌐 English ⚖ 411 KB